Return On Equity of Nabriva Therapeutics plc from 30 Sep 2017 to 30 Jun 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nabriva Therapeutics plc quarterly and annual Return On Equity in % history and change rate from 30 Sep 2017 to 30 Jun 2023.
  • Nabriva Therapeutics plc Return On Equity for the quarter ending 30 Jun 2023 was -2673%, a 2708% decline year-over-year.
  • Nabriva Therapeutics plc annual Return On Equity for 2022 was -212%, a 158% decline from 2021.
  • Nabriva Therapeutics plc annual Return On Equity for 2021 was -82%, a 60% increase from 2020.
  • Nabriva Therapeutics plc annual Return On Equity for 2020 was -208%, a 16% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Nabriva Therapeutics plc Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2023 -2673% -2578% -2708% 01 Apr 2023 30 Jun 2023
Q1 2023 -366% -283% -345% 01 Jan 2023 31 Mar 2023
Q4 2022 -212% -129% -158% 01 Oct 2022 31 Dec 2022
Q3 2022 -120% -22% -22% 01 Jul 2022 30 Sep 2022
Q2 2022 -95% +22% +19% 01 Apr 2022 30 Jun 2022
Q1 2022 -82% +61% +42% 01 Jan 2022 31 Mar 2022
Q4 2021 -82% +126% +60% 01 Oct 2021 31 Dec 2021
Q3 2021 -98% +112% +53% 01 Jul 2021 30 Sep 2021
Q2 2021 -117% +103% +47% 01 Apr 2021 30 Jun 2021
Q1 2021 -143% +96% +40% 01 Jan 2021 31 Mar 2021
Q4 2020 -208% -28% -16% 01 Oct 2020 31 Dec 2020
Q3 2020 -211% -39% -23% 01 Jul 2020 30 Sep 2020
Q2 2020 -220% -33% -17% 01 Apr 2020 30 Jun 2020
Q1 2020 -239% -76% -47% 01 Jan 2020 31 Mar 2020
Q4 2019 -180% -40% -29% 01 Oct 2019 31 Dec 2019
Q3 2019 -171% -47% -38% 01 Jul 2019 30 Sep 2019
Q2 2019 -187% -100% -115% 01 Apr 2019 30 Jun 2019
Q1 2019 -162% -73% -81% 01 Jan 2019 31 Mar 2019
Q4 2018 -140% -40% -40% 01 Oct 2018 31 Dec 2018
Q3 2018 -124% -32% -35% 01 Jul 2018 30 Sep 2018
Q2 2018 -87% 01 Apr 2018 30 Jun 2018
Q1 2018 -90% 01 Jan 2018 31 Mar 2018
Q4 2017 -100% 01 Oct 2017 31 Dec 2017
Q3 2017 -92% 01 Jul 2017 30 Sep 2017

Nabriva Therapeutics plc Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -212% -129% -158% 01 Jan 2022 31 Dec 2022
2021 -82% +126% +60% 01 Jan 2021 31 Dec 2021
2020 -208% -28% -16% 01 Jan 2020 31 Dec 2020
2019 -180% -40% -29% 01 Jan 2019 31 Dec 2019
2018 -140% -40% -40% 01 Jan 2018 31 Dec 2018
2017 -100% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.